glp-1 gip therapy effectiveness muscle preservation Frontiers Main physiological actions of the
Description
Changes in eating behaviour and meal pattern following Roux-en-Y gastric bypass
Almandoz at UT Southwestern: "We found that fewer than 1 in 4 patients remained on a GLP-1 medication after a year." Less than 25%
It may be that you are not as hungry as you used to be and eat less because of the medication, so a fiber supplement may be indicated
The GLP-1 analog is considered beneficial in clinical practice, principally by being used in the treatment or the complementary therapy of T2DM
Explicar que el peso puede volver al dejar el frmaco si no hay cambios en el estilo de vida
